LATEST
Novartis and Molecular Partners Finalize $230 Million Pact for New Class of COVID-19 Antivirals
2022-01-19
Japan’s Ono Pharmaceutical Expands Collab with Neurimmune to Discover Antibodies for Neurodegenerative Disorders
2022-01-18
Sex Dimorphism in Obesity and the Impact of Estrogen Hormone Therapy on Cardiometabolic Health
2022-01-17
Study Reveals a Form of Four-Stranded DNA that Links Protein Deficiency and Premature Aging
2022-01-17
Shanghai’s Everest Medicines Licenses COVID-19 Oral Antivirals from Singapore’s National Drug Discovery Platform
2022-01-17
Digital Health Programme to Connect British and Taiwanese Leaders
2022-01-17Partner
Concerns Remain as Kintor Pharma’s Proxalutamide Shows Unbelievably High Efficacy Against Covid-19 Infections in Phase 3 Trials
2022-01-16